The Fourth Annual Regulatory Symposium, Sept. 30-Oct. 2, 2009, in Washington, D.C., is only two days away and the entire event can is accessible both onsite and online.
The Symposium features a Who's Who of FDA's new leadership, including FDA Commissioner Margaret Hamburg, CDER Director Janet Woodcock, CDER Associate Director for Medical Policy Robert Temple, along with an array of other agency officials on the key regulatory issues facing drug and device companies. The agency's key decision makers will be joined by numerous industry thought leaders and outside experts to address the agency's regulatory and enforcement priorities. To review the entire agenda, visit: www.fdasymposium.com.
Topics covered in this FDA regulatory event include:
- FDA's Regulatory Agenda: Margaret Hamburg, FDA Commissioner
- Comparative Effectiveness: Robert Temple, CDER, FDA
- FDA's Safe Use Initiative: Janet Woodcock, CDER, FDA
- FDA Enforcement: Tom Abrams, CDER, FDA
- FDA's Device Approval and Safety Initiatives: Jonathan Sackner Bernstein, MD, CDRH, FDA
- The Agency's Approach to Social Media: Sanjay Koyani, FDA
In addition, five former FDA Chief Counsel to will address Off-Label Promotion, Enforcement, Preemption, and other key issues.
Also, industry thought leaders and outside experts will address the latest developments in Enforcement, Drug Safety, Risk Management and Social Media.
Conference Co-Chair Peter Pitts, the President of the Center for Medicine in the Public Interest, will steer the discussion on Day One and join other industry experts in assessing the industry's latest efforts related to managing conflicts of interest as part of a special panel discussion.
Date: Wednesday, Sept. 30 – Friday, Oct. 2, 2009
Location
Renaissance Washington DC Hotel
999 9th Street, N.W.
Washington DC 20001
Via the Web
The entire event can be accessed from the convenience of your office by visiting: www.fdasymposium.com/registration.html
For more details please visit www.fdasymposium.com